Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: Differential regulation of specific exons by antidepressants and corticosterone

Neuroscience

Volumn 139, Issue 3, 2006, Pages 1017-1029

  Dwivedi, Y ^a   Rizavi, H S ^a   Pandey, G N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

antidepressants; BDNF; depression; exons; glucocorticoid; mRNA

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; DESIPRAMINE; FLUOXETINE; PHENELZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXON; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; RNA ANALYSIS;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; DESIPRAMINE; DRUG IMPLANTS; EXONS; FLUOXETINE; GENE EXPRESSION; MALE; PHENELZINE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 33646150655     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2005.12.058     Document Type: Article

References (91)

1. Altieri M., Marini F., Arban R., Vitulli G., and Jansson B.O. Expression analysis of brain-derived neurotrophin factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment. Brain Res 1000 (2004) 148-155
2. Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 29 (2004) 185-193
3. Benraiss A., Chmielnicki E., Lerner K., Roh D., and Goldman S.A. Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J Neurosci 21 (2001) 6718-6731
4. Budziszewska B. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function. Pol J Pharmacol 54 (2002) 343-349
5. Budziszewska B., Jaworska-Feil L., Kajta M., and Lason W. Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription. a possible mechanism. Br J Pharmacol 130 (2000) 1385-1393
6. Carroll B.J., Curtis G.C., and Mendels J. Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med 6 (1976) 235-244
7. Chao H.M., and McEwen B.S. Glucocorticoids and the expression of mRNAs for neurotrophins, their receptors and GAP-43 in the rat hippocampus. Brain Res Mol Brain Res 26 (1994) 271-276
8. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.-F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50 (2001) 260-265
9. Conti A.C., Cryan J.F., Dalvi A., Lucki I., and Blendy J.A. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22 (2002) 3262-3268
10. Coppell A., Pei Q., and Zetterston T.S.C. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44 (2003) 903-910
11. De Foubert G., Carney S.L., Robinson C.S., Destexhe E.J., Tomlinson R., Hicks C.A., Murray T.K., Gaillard J.P., Deville C., Xhenseval V., Thomas C.E., O'Neill M.J., and Zetterstrom T.S.C. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128 (2004) 597-604
12. Dias B.G., Banerjee S.B., Duman R.S., and Vaidya V.A. Differential regulation of brain-derived neurotrophin factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45 (2003) 553-563
13. Drevets W.C. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 126 (2000) 413-431
14. Dwivedi Y., Agrawal A.K., Rizavi H.S., and Pandey G.N. Antidepressants reduce phosphoinositide-specific phospholipase C (PI-PLC) activity and the mRNA and protein expression of selective PLC β1 isozyme in rat brain. Neuropharmacology 43 (2002) 1269-1279
15. Dwivedi Y., and Pandey G.N. Effects of subchronic administration of antidepressants and anxiolytics on levels of the α subunits of G proteins in the rat brain. J Neural Transm 104 (1997) 747-760
16. 3H]cyclic AMP binding to protein kinase A (PKA), cyclic AMP-dependent PKA activity, and protein levels of selective regulatory and catalytic subunit isoforms of PKA in rat brain. J Pharmacol Exp Ther 294 (2000) 103-116
17. Dwivedi Y., Rizavi H.S., Rao J.S., and Pandey G.N. Modifications in the phosphoinositide signaling pathway by adrenal glucocorticoids in rat brain. focus on phosphoinositide-specific phospholipase C and inositol 1,4,5-trisphosphate. J Pharmacol Exp Ther 295 (2000) 244-254
18. Dwivedi Y., Pandey S.C., Ren X., Tueting P., and Pandey G.N. Effect of desipramine, lithium, and adinazolam on serotonin receptor subtypes in rat brain. Soc Neurosci Abstr 20 (1994) 1161
19. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., and Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60 (2003) 804-815
20. Falkenberg T., Metsis M., Timmusk T., and Lindefors N. Entorhinal cortex regulation of multiple brain-derived neurotrophic factor promoters in the rat hippocampus. Neuroscience 57 (1992) 891-896
21. Gass P., Kretz O., Wolfer D.P., Berger S., Tronche F., Reinchardt H.M., Kellendonk C., Lipp H.P., Schmid W., and Schutz G. Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice. EMBO Rep 1 (2003) 447-451
22. Gervasoni N., Aubry J.M., Bondolfi G., Osiek C., Schwald M., Bertschy G., and Karege F. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51 (2005) 234-238
23. Gold P.W., Goodwin F.K., and Chrousos G.P. Clinical and biochemical manifestations of depression. Relation to neurobiology of stress (part II). N Engl J Med 6 (1988) 413-420
24. Gould E., McEwen B., Tanapat P., Galea L., and Fuchs E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 17 (1997) 2492-2498
25. Hayes V.Y., Towner M.D., and Isackson P.J. Organization, sequence and functional analysis of a mouse BDNF promoter. Mol Brain Res 45 (1997) 189-198
26. Heuser I.J.E., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M., Yassouridis A., and Holsboer F. Pituitary-adrenal system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J Psychiatry 153 (1996) 93-99
27. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy: review article. J Affect Disord 62 (2001) 77-91
28. Holsboer F., and Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 17 (1996) 187-205
29. Imai E., Miner J.N., Mitchell J.A., Yamamoto K.R., and Granner D.K. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 268 (1993) 5353-5356
30. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M., and Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57 (2005) 1068-1072
31. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., and Aubry J.-M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109 (2002) 143-148
32. Kitayama L., Janson A.M., Cintra A., Fuxe K., Agnati L.F., Ogren S.O., Harfstrand A., Eneroth P., and Gustafsson J.A. Effects of chronic imipramine treatment on gluocorticoid receptor immunoreactivity in various regions of the rat brain. J Neural Transm 73 (1988) 191-203
33. Lauterborn J.C., Poulsen F.R., Stinis C.T., Isackson P.J., and Gail C.M. Transcript-specific effects of adrenalectomy on seizure-induced BDNF expression in rat hippocampus. Mol Brain Res 55 (1998) 81-91
34. Lindeforts N., Brodin E., and Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience 65 (1995) 661-670
35. Magarinos A.M., McEwen B.S., Flugge G., and Fuchs E. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci 16 (1996) 3534-3540
36. Mann C.D., Bich V.T., and Hrdina P.D. Protein kinase C in rat brain cortex and hippocampus. effects of repeated administration of fluoxetine and desipramine. Br J Pharmacol 115 (1995) 595-600
37. Marmigere F., Givalois L., Rage F., Arancibia S., and Tapia-Arancibia L. Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus 13 (2003) 646-655
38. McEwen B.S. Glucocorticoid-biogenic amine interactions in reaction in mood and behavior. Biochem Pharmacol 36 (1987) 1755-1763
39. McEwen B.S. Stress and hippocampal plasticity. Annu Rev Neurosci 22 (1999) 105-122
40. Miro X., Perez-Torres F., Artigas P., Puigdomenech J.M., Palacios G., and Mengod. Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology 43 (2002) 1148-1157
41. Montkowski A., Barden N., Wotjak C., Stec I., Ganster J., Meaney M., Engelmann M., Reul J.M.H.M., Landgraf R., and Holsboer F. Long-term antidepressant treatment reduces behavioral deficits in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol 7 (1995) 841-845
42. Murphy B.E.F. Steroids and depression. J Steroid Biochem Mol Biol 38 (1991) 537-539
43. Murray K.D., Hayes V.Y., Gall C.M., and Isackson P.J. Attenuation of the seizure-induced expression of BDNF mRNA in adult rat brain by an inhibitor of calcium/calmodulin-dependent protein kinases. Eur J Neurosci 10 (1998) 377-387
44. Nakayama M., Gahara Y., Kitamura T., and Ohara O. Distinctive four promoters collectively direct expression of brain-derived neurotrophic factor gene. Mol Brain Res 21 (1994) 206-218
45. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Neuroscience 15 (1995) 7539-7547
46. Nibuya M., Nestler E.J., and Duman R.S. Chronic antidepressant administration increases the expression of cAMP-response element binding protein (CREB) in rat hippocampus. J Neurosci 16 (1996) 2365-2372
47. Nibuya M., Takahashi M., Russell D.S., and Duman R.S. Chronic stress increases catalytic trkB mRNA in rat hippocampus. Neurosci Lett 267 (1999) 81-84
48. Okada F., Tokumitsu Y., and Ui M. Possible involvement of pertussis toxin substrates (Gi, Go) in desipramine-induced refractoriness of adenylate cyclase in cerebral cortices of rates. J Neurochem 51 (1988) 194-199
49. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 95 (1998) 13290-13295
50. s to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J Neurochem 56 (1991) 330-338
51. Pandey G.N., Pandey S.C., and Davis J.M. Effect of desipramine on inositol phosphate formation and inositol phospholipids in rat brain and human platelets. Psychopharmacol Bull 27 (1991) 255-261
52. Pariante C.M. Depression, stress and the adrenal axis. J Neuroendocrinol 15 (2003) 811-812
53. Pariante C.M., and Miller A.H. Glucocorticoid receptors in major depression. relevance to pathophysiology and treatment. Biol Psychiatry 49 (2001) 391-404
54. Pariante C.M., Thomas S.A., Lovestone S., Makoff A., and Kerwin R.W. Do antidepressants regulate how cortisol affects the brain?. Psychoneuroendocrinology 29 (2004) 423-447
55. Peiffer A., Veilleux S., and Barden N. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor mRNA levels in rat brains. Psychoneuroendocrinology 16 (1991) 505-515
56. Pepin M.C., Govindan M.V., and Barden N. Increased glucocorticoid receptor gene promoter activity following antidepressant treatment. Mol Pharmacol 41 (1992) 1016-1022
57. Pepin M.-C., Pothier F., and Barden N. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol 42 (1992) 991-995
58. Rage F., Givalois L., Marmigere F., Tapia-Arancibia L., and Arancibia S. Immobilization stress rapidly modulates BDNF mRNA expression in the hypothalamus of adult male rats. Neuroscience 112 (2002) 309-318
59. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., Overholser J.C., Roth B.L., and Stockmeier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45 (1999) 1083-1084
60. Rasmussen A., Shi L., and Duman R.S. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology 27 (2002) 133-142
61. Reagen L., and McEwen B. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. J Chem Neuroanat 13 (1997) 148-158
62. Reul J.M.H.M., Labeur M.S., Grigoriadis D.E., De Souza E.B., and Holsboer F. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology 60 (1994) 509-519
63. Reul J.M.H.M., Stec I., Soder M., and Holsboer F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133 (1993) 312-320
64. Russo-Neustadt A., Beard R.C., and Cotman C.W. Exercise, antidepressant medications, and enhanced brain-derived neurotrophic factor expression. Neuropsychopharmacology 21 (1999) 679
65. Russo-Neustadt A.A., Beard R.C., Huang Y.M., and Cotman C.W. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 101 (2000) 305-312
66. Russo-Neustadt A.B.R., and Cotman C.W. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21 (1999) 679-682
67. Sapolsky R. Glucocorticoids, stress, and their adverse neurological effects. relevance to aging. Exp Gerontol 34 (1999) 721-729
68. Sapolsky R. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57 (2000) 925-935
69. Schaaf M.J.M., de Jong J., de Kloet E.R., and Vreugdenhil E. Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res 813 (1998) 112-120
70. Schaaf M.J., de Kloet E.R., and Vreugdenhil E. Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation. Stress 30 (2000) 201-208
71. Schaaf M.J., Hoetelmans R.W.M., de Kloet E.R., and Vreugdenhil E. Corticosterone regulates expression of BDNF and trkB but not NT-3 and trkC mRNA in the rat hippocampus. J Neurosci Res 48 (1997) 334-341
72. Seckl J.R., and Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 55 (1992) 621-626
73. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., and Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93 (1996) 3908-3913
74. Shieh P.B., Hu S.C., Bobb K., Timmusk T., and Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 20 (1998) 727-740
75. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., Nakazato M., Watanabe H., Shinoda N., Okada S.-I., and Iyo M. Alterations of serum levels of brain-derived neurotrophin factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54 (2003) 70-75
76. Slotkin T.A., Zhang J., McCook E.C., and Seidler J.F. Glucocorticoid administration alters nuclear transcription factors in fetal rat brain. implications for the use of antenatal steroids. Brain Res Dev Brain Res 111 (1998) 11-24
77. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15 (1995) 1768-1777
78. Stauber C., Altschmied J., Akerblom I.E., Marrow J.L., and Mellon P.L. Mutual cross-interference between glucocorticoid receptor and CREB inhibits transactivation in placental cells. New Biol 4 (1992) 527-540
79. 2+/calmodulin-dependent protein kinase II. J Neurochem 74 (2000) 1913-1922
80. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20 (1998) 709-726
81. Tao X., West A.E., Chen W.G., Corfas G., and Greenberg M.E. A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF. Neuron 33 (2002) 383-395
82. Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., Storm D., and Duman R.S. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 20 (2000) 4030-4036
83. Timmusk T., and Metsis M. Regulation of BDNF promoters in the rat hippocampus. Neurochem Int 25 (1994) 11-15
84. Timmusk T., Palm K., Mesis M., Reintam T., Paalme V., Saarma M., and Persson H. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10 (1993) 475-489
85. 2A receptors without affecting benzodiazepine binding sites in rat brain. Cell Mol Neurobiol 15 (1995) 361-370
86. Trouvin J.H., Gardier A.M., Chanut E., Pages N., and Jacquot C. Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat. Life Sci 52 (1993) 187-192
87. Ueyama T., Kawai Y., Nemoto K., Sekimoto M., Tone S., and Senba E. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 28 (1997) 103-110
88. Ulrichsen J., Partilla J.S., and Dax E.M. Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion. Psychopharmacology 107 (1992) 229-235
89. Unlap T., and Jope R.S. Dexamethasone attenuates kainate-induced AP-1 activation in rat brain. Brain Res Mol Brain Res 24 (1994) 275-282
90. Xu H., Richardson J.S., and Li X.M. Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 28 (2003) 53-62
91. Young E.A., Lopez J.F., Murphy-Weinberg V., Watson S.J., and Akil H. Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 60 (2003) 24-28